Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-24-022252

CEO and President gave up 240 shares (to pay taxes)

  • CEO and President acquired 982 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
KLEMP WALTER V CEO and President 2024-07-02 Option exercise +982 57,275 D
KLEMP WALTER V CEO and President 2024-07-02 Shares withheld for taxes −240 $3.57 $857 57,035 D
Derivatives
KLEMP WALTER V CEO and President 2024-07-02 Option exercise · Restricted Stock Units −982 113,152 D
Loading xslF345X05/rdgdoc.xml…